Differentiated service delivery models for AHD specifically have only started to gain prominence in recent years and thus far primarily focus on the availability of a package of rapid diagnostic tests for CD4 count, cryptococcal disease and tuberculosis, coupled with therapeutics to prevent and treat these infections (Differentiated Service Delivery, 2019). This evidence concerns the gene CD4 and infection.